Labcyte Names Chris Grimley as Vice President of Marketing

Labcyte Inc., the company revolutionizing life science research with the Echo® liquid handler, today announced the appointment of Chris Grimley as Vice President of Marketing. Mr. Grimley will be responsible for leading the global marketing and product management teams, driving demand for products and services, and growing sales of the Echo liquid handler in emerging application areas such as in synthetic biology, next generation sequencing and personalized medicine.

February 09, 2015
SUNNYVALE, CA
Labcyte Inc., the company revolutionizing life science research with the Echo® liquid handler, today announced the appointment of Chris Grimley as Vice President of Marketing. Mr. Grimley will be responsible for leading the global marketing and product management teams, driving demand for products and services, and growing sales of the Echo liquid handler in emerging application areas such as in synthetic biology, next generation sequencing and personalized medicine.

Mr. Grimley joins Labcyte with over 20 years of experience in the life science industry and was most recently Vice President of Marketing at NanoString Technologies, Inc. Previously he served as Senior Director of Marketing at Agilent Technologies, where he headed marketing for the company’s genomics portfolio. Mr. Grimley began his career in the life science business at Applied Biosystems (now part of Thermo Fisher Scientific) where from 1994 to 2008 he held positions of increasing responsibility including Director of Marketing for the company’s real-time PCR instrument portfolio. He received his Bachelor of Science degree in Biochemistry from San Francisco State University.

“Chris has broad experience and an impressive track record in the life sciences industry,” said Mark Fischer-Colbrie, President and Chief Executive Officer for Labcyte. “His extensive knowledge of the genomics market will be invaluable to support the ongoing rapid adoption of our disruptive technology which reduces costs, improves workflows and provides superior data quality.”

"Labcyte’s acoustic liquid handling technology is transforming an ever expanding number of applications,” said Mr. Grimley. “A particularly exciting example is the recent clinical research highlighting how the unique capabilities of the Echo liquid handler can enable treatment strategies tailored to individual patients - truly personalized medicine. I am delighted to join the company and I look forward to contributing to the future of this innovative technology platform."

About Labcyte
Labcyte, a global biotechnology tools company headquartered in Sunnyvale, California, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, precision medicine, and imaging mass spectrometry. Labcyte has 55 U.S. patents and others internationally. For more information, visit www.labcyte.com.